Page 99 - Read Online
P. 99

Page 4 of 16            Cadamuro et al. Hepatoma Res 2022;8:11  https://dx.doi.org/10.20517/2394-5079.2021.140































                Figure 1. Tumor microenvironment. (A) Intrahepatic cholangiocarcinoma (hematoxylin and eosin stain, magnification 200×): black
                arrow, cancer-associated fibroblasts; green arrow, neutrophils; red arrow, tumor-infiltrating lymphocytes; long black arrow, microvessel.
                (B) Cancer-associated fibroblasts in the desmoplastic stroma are immunoreactive for α-smooth muscle actin, a biomarker of
                myofibroblast differentiation (immunohistochemistry, 200×). (C) Microvessels are highlighted by CD34 immunostain. (D) Tumor-
                infiltrating CD4 positive lymphocytes are highlighted by CD4 immunostain. (E) Tumor-infiltrating CD8 positive lymphocytes are
                highlighted by CD8 immunostain. (F) Tumor-associated neutrophils are highlighted by myeloperoxidase immunostain. (B-F) Brown
                stain indicates positive (mmunohistochemistry, magnification 200×).

               increase in tumor size and lymphatic metastasis and reduced overall survival [3,12] . These non-structural ECM
               proteins have an important role during embryonic development but in adult life are only expressed during
               tissue remodeling and wound repair [18-20] . POSTN can act as both a promoter and a suppressor of cancer cell
               invasiveness, interacting with other ECM proteins, such as collagen types I and V, fibronectin, TnC, and
               heparin, and contribute to the activation of pathways of tissue remodeling, fibrogenesis, cell motility,
               angiogenesis, tumor invasiveness, and metastasis. POSTN and TnC cooperate to promote metastasis
               through the activation of the Wnt and Notch signaling. POSTN is also capable of recruiting TAM, making
                                                                           [21]
               this matrix protein a potential curative target for drug development . TnC binds many ECM proteins,
               including fibronectin, POSTN, collagen, fibrillin-2, and proteoglycans, probably playing a structural role
               and defining the stiffness of the microenvironment. In iCCA, TnC is selectively expressed by the tumor
               invasion  front,  and  its  expression  correlates  with  adverse  outcomes . OPN  is  a  glycosylated
                                                                                 [22]
               phosphoprotein produced by many cell types that is normally involved in bone remodeling, immune-
               regulation, inflammation, and vascularization. The role of OPN in CCA has been covered recently [23,24] . OPN
               is in fact an important regulator of the repair response based on the progenitor liver cells that produce it
               and with an autocrine loop stimulates their proliferation and migration, which eventually leads to the
               ductular reaction. It also regulates the interaction between these cells and stromal cells; for example,
               through the mediation with transforming growth factor (TGF) β, it allows the activation of the fibroblasts
               that produce the other proteins, as well as the migration of macrophages [23,24] . For further information on the
               tumor matrix, see the work of Fabris et al. .
                                                  [25]

               Cancer-associated fibroblasts
               CAFs, the most represented cell type in the TME, are cells of mesenchymal origin that lay embedded into
               the tumoral ECM and have a prominent role in the production of ECM components and the degradation of
   94   95   96   97   98   99   100   101   102   103   104